Cohort study of the association of hypnotic use with mortality in postmenopausal women

BMJ Open

Volumn 2, Issue 5, 2012, Pages

  Hartz, Arthur ^a   Ross, John Jacob ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; APPETITE DISORDER; ARTICLE; BREAST CANCER; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DRUG FATALITY; DRUG USE; FEMALE; FOLLOW UP; GEOGRAPHY; GROUPS BY AGE; HEALTH STATUS; HEART INFARCTION; HUMAN; INCIDENCE; INCOME; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MELANOMA; MORTALITY; OUTCOME ASSESSMENT; OVARY CANCER; POSTMENOPAUSE; RISK ASSESSMENT; SLEEP DISORDER; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84869806471     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001413     Document Type: Article

References (28)

1. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411-18.
2. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 2003;45:344-50.
3. Nilsson PM, Roost M, Engstrom G, et al. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 2004;27:2464-9.
4. Asplund R. Sleep and cardiac diseases amongst elderly people. J Intern Med 1994;236:65-71.
5. Rabin RC. New worries about sleeping pills. Well: New York Times, 2012.
6. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia. JAMA 2009;301:2005-15.
7. Curran HV, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003;33:1223-37.
8. Ohayon MM, Caulet M, Arbus L, et al. Are prescribed medications effective in the treatment of insomnia complaints? J Psychosom Res 1999;47:359-68.
9. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012;2:e000850.
10. Greene G. The case for sleep medicine. New York Times, 2012:SR14.
11. Belleville G. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. CanJ Psychiatry 2010;55:558-67.
12. Hausken AM, Skurtveit S, Tverdal A. Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population. Pharmacoepidemio Drug Saf 2007;16:913-18.
13. Hublin C, Partinen M, Koskenvuo M, et al. Sleep and mortality: a population-based 22-year follow-up study. Sleep 2007;30:1245-53.
14. Kojima M, Wakai K, Kawamura T, et al. Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol/Jap Epidemiol Assoc 2000;10:87-93.
15. Kripke DF. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res 2008;17:245-50.
16. Kripke DF, Garfinkel L, Wingard DL, et al. Mortality associated with sleep duration and insomnia. Arc Gen Psychiatry 2002;59:131-6.
17. Mallon L, Broman JE, Hetta J. Is usage of hypnotics associated with mortality? Sleep Med 2009;10:279-86.
18. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997;7:568-74.
19. Kao CH, Sun LM, Liang JA, et al. Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin Proc. Mayo Clinic 2012;87:430-6.
20. Taubes G. Do we really know what makes us healthy? New York Times 2007.
21. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
22. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13(9 Suppl):S5-17.
23. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003;13(9 Suppl):S122-8.
24. Rod NH, Vahtera J, Westerlund H, et al. Sleep disturbances and cause-specific mortality: results from the GAZEL cohort study. Am J Epidemiol 2011;173:300-9.
25. Hartz A, Houts P, Arnold S, et al. A method to quantify confounding in regression analyses applied to data on diet and CHD incidence. J Clin Epidemiol 1988;41:331-7.
26. Vozoris NT, Leung RS. Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data. Sleep 2011;34:869-74.
27. Kripke DF, Klauber MR, Wingard DL, et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998;43:687-93.
28. Phillips B, Mannino DM. Does insomnia kill? Sleep 2005;28:965-71.